JP2005306886A - External agent composition - Google Patents

External agent composition Download PDF

Info

Publication number
JP2005306886A
JP2005306886A JP2005207051A JP2005207051A JP2005306886A JP 2005306886 A JP2005306886 A JP 2005306886A JP 2005207051 A JP2005207051 A JP 2005207051A JP 2005207051 A JP2005207051 A JP 2005207051A JP 2005306886 A JP2005306886 A JP 2005306886A
Authority
JP
Japan
Prior art keywords
carbon atoms
same
different
hydrocarbon group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005207051A
Other languages
Japanese (ja)
Other versions
JP4150738B2 (en
Inventor
Tadahide Hoshino
匡秀 星野
Hiroaki Saito
裕映 斉藤
Yoshiya Sugai
由也 菅井
Mitsuru Sugiyama
充 杉山
Yoshinori Nishizawa
義則 西澤
Yasushi Katayama
靖 片山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2005207051A priority Critical patent/JP4150738B2/en
Publication of JP2005306886A publication Critical patent/JP2005306886A/en
Application granted granted Critical
Publication of JP4150738B2 publication Critical patent/JP4150738B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an external agent composition, basically improving the water retaining ability and barrier functions of the horny layer, excellent in miscibility and mixing stability and capable of being efficiently prepared at a low cost. <P>SOLUTION: This external agent composition, a humectant and a skin barrier function reinforcing agent, contain each a diamide derivative represented by formula (1) (wherein, R<SP>1a</SP>and R<SP>1b</SP>are the same or different and represent each a 1-23C branched chain hydrocarbon; R<SP>2a</SP>and R<SP>2b</SP>are the same or different and represent each a 1-6C divalent hydrocarbon; R<SP>3</SP>s are the same or different and represent each a 2-6C divalent hydrocarbon; and (n) stands for 1 to 100). <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、皮膚角質層の正常なバリアー機能の維持及び水分保持力の向上によって肌荒れ改善効果等を発揮する化合物及びこれを含有する外用剤組成物に関する。   The present invention relates to a compound that exhibits an effect of improving rough skin by maintaining a normal barrier function of the stratum corneum and improving water retention, and an external preparation composition containing the same.

角質層の水分保持能力、バリアー機能が種々の内的原因、或いは外的原因により低下すると、肌荒れや老化を助長する等の様々な皮膚トラブルを起こす。また、アトピー性皮膚炎、乾癬、乾皮症等の種々の皮膚疾患に見られる肌荒れ症状においても、角質層の水分保持能力、バリアー機能の低下が認められている。従って、角質層の水分保持能力、バリアー機能の維持・補強は、人の健全な日常生活を行う上において大変重要である。   When the moisture retention ability and barrier function of the stratum corneum are reduced due to various internal causes or external causes, various skin troubles such as promoting rough skin and aging are caused. Moreover, in the rough skin symptom seen in various skin diseases such as atopic dermatitis, psoriasis and psoriasis, a decrease in water retention ability and barrier function of the stratum corneum is recognized. Therefore, the maintenance and reinforcement of the stratum corneum's ability to retain moisture and the barrier function are very important in conducting healthy daily life.

斯かる状況の下、本出願人は角質層のバリアー機能を本質的に改善(維持、補強)する効果を有する皮膚外用剤として、下記一般式(2)で表されるアミド誘導体を含有する皮膚外用剤等を見出し先に特許出願した(特許文献1)。   Under such circumstances, the applicant of the present invention is a skin containing an amide derivative represented by the following general formula (2) as an external preparation for skin having an effect of essentially improving (maintaining, reinforcing) the barrier function of the stratum corneum. A patent application was filed for the topical preparation for external use (Patent Document 1).

(式中、Raは炭素数10〜40の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基を示し、Rbは炭素数3〜39の直鎖又は分岐鎖の二価の炭化水素基を示し、Rcは水素原子、炭素数10〜40の直鎖若しくは分岐鎖の飽和若しくは不飽和の炭化水素基又はアシル基を示す。) (In the formula, R a represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R b represents a linear or branched divalent hydrocarbon group having 3 to 39 carbon atoms. R c represents a hydrogen atom, a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, or an acyl group.)

しかしながら、斯かるアミド誘導体は、上記の優れた効果をもたらすものであるが、基剤に対する溶解性や安定性が必ずしも十分でないため、皮膚外用剤に配合する場合の配合性や配合安定性の点で改善の余地が残されていた。また、これらのアミド誘導体の製造には多段階の反応を必要とし、必然的に製造コストが高くなるという問題もあった。
特開平4−128256号公報
However, such amide derivatives bring about the above-mentioned excellent effects, but the solubility and stability with respect to the base are not necessarily sufficient. There was still room for improvement. In addition, the production of these amide derivatives requires a multi-step reaction, which inevitably increases the production cost.
JP-A-4-128256

本発明は、角質層の水分保持能力及びバリアー機能を本質的に改善すると共に配合性や配合安定性等に優れ、且つ効率的で安価に製造できる外用剤組成物を提供することを目的とする。   An object of the present invention is to provide an external preparation composition that substantially improves the moisture retention ability and barrier function of the stratum corneum and is excellent in blending and blending stability and can be produced efficiently and inexpensively. .

本発明者らは、アミド誘導体について更に検討したところ、下記式(1)で示されるジアミド誘導体が角質層の水分保持能力の増強作用及びバリアー機能改善作用を有すると共に優れた配合性や配合安定性を併せ持ち、肌荒れ等の皮膚トラブルの予防・改善効果、毛髪保護効果を有する外用剤組成物として有用であることを見出した。   When the present inventors further examined the amide derivative, the diamide derivative represented by the following formula (1) has an action of enhancing the water retention ability and an improvement of the barrier function of the stratum corneum, and has excellent blendability and blending stability. And was found to be useful as an external preparation composition having an effect of preventing and improving skin troubles such as rough skin and a hair protecting effect.

すなわち本発明は、次の一般式(1):   That is, the present invention provides the following general formula (1):

(式中、R1a及びR1bは同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体を含有する外用剤組成物、該ジアミド誘導体及び角質細胞間脂質成分を含有する外用剤組成物、該ジアミド誘導体を有効成分とする保湿剤及び皮膚バリアー機能補強剤を提供するものである。
Wherein R 1a and R 1b are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent hydrocarbons having 1 to 6 carbon atoms. And R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
An external preparation composition containing the diamide derivative represented by the formula, an external preparation composition containing the diamide derivative and a keratinocyte lipid component, a moisturizer and a skin barrier function reinforcing agent containing the diamide derivative as active ingredients. Is.

更に本発明は、次の一般式(1'):   Furthermore, the present invention provides the following general formula (1 ′):

(式中、R1a'及びR1b'は同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体を提供するものである。
(Wherein R 1a ′ and R 1b ′ are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent carbon atoms having 1 to 6 carbon atoms. A hydrocarbon group, R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
The diamide derivative represented by these is provided.

本発明のジアミド誘導体(1)は、角質細胞間の脂質層に浸透して角質層の水分保持能力とバリアー機能を改善(維持・補強)し、毛髪に浸透してその保護効果を高める作用を有すると共に基剤に対する良好な溶解性と優れた安定性を有する。従って、本発明の外用剤組成物、保湿剤及び皮膚バリアー機能補強剤は、肌荒れの予防・治療、皮膚の老化予防、毛髪の感触向上、頭皮の荒れの予防・改善等の効果を発揮し、安定性に優れた医薬品、化粧品、医薬部外品として有用である。さらに、本発明の外用剤組成物は効率的且つ安価に製造することができる。   The diamide derivative (1) of the present invention permeates the lipid layer between the stratum corneum and improves (maintains / reinforces) the water retention ability and barrier function of the stratum corneum, and acts to enhance the protective effect by penetrating into the hair. As well as having good solubility in the base and excellent stability. Therefore, the external preparation composition, moisturizing agent and skin barrier function reinforcing agent of the present invention exhibit effects such as prevention and treatment of rough skin, prevention of skin aging, improvement of hair feel, prevention and improvement of scalp roughness, It is useful as a pharmaceutical, cosmetic, and quasi-drug with excellent stability. Furthermore, the external preparation composition of the present invention can be produced efficiently and inexpensively.

本発明のジアミド誘導体(1)において、R1a及びR1bで示される炭素数1〜23の炭化水素基としては、炭素数5〜17の直鎖又は分岐鎖のアルキル基又はアルケニル基が好ましく、更にR1a及びR1bが同一である場合が好ましい。特に好ましい炭化水素基としてはペンチル、ヘプチル、ノニル、ウンデシル、トリデシル、ペンタデシル、ヘプタデシル、1−エチルヘプチル、2,4,4−トリメチルペンチル、1−ヘプチルデシル、イソヘプタデシル、メチル分岐イソヘプタデシル、8−ヘプタデセニル、8,11−ヘプタデカジエニル基等が挙げられる。 In the diamide derivative (1) of the present invention, the hydrocarbon group having 1 to 23 carbon atoms represented by R 1a and R 1b is preferably a linear or branched alkyl group or alkenyl group having 5 to 17 carbon atoms, Furthermore, it is preferable that R 1a and R 1b are the same. Particularly preferred hydrocarbon groups include pentyl, heptyl, nonyl, undecyl, tridecyl, pentadecyl, heptadecyl, 1-ethylheptyl, 2,4,4-trimethylpentyl, 1-heptyldecyl, isoheptadecyl, methyl branched isoheptadecyl, 8-heptadecenyl, 8 , 11-heptadecadienyl group and the like.

ここで、R1a及びR1bが炭素数4以上の分岐鎖の炭化水素基である一般式(1')で示される化合物は新規化合物である。 Here, the compound represented by the general formula (1 ′) in which R 1a and R 1b are branched hydrocarbon groups having 4 or more carbon atoms is a novel compound.

2a及びR2bで示される炭素数1〜6の二価の炭化水素基としては、炭素数2〜6の直鎖又は分岐鎖のアルキレン基が好ましく、更にR2a及びR2bが同一である場合が好ましい。特に好ましい二価の炭化水素基としてはエチレン、トリメチレン、テトラメチレン、ペンタメチレン、ヘキサメチレン、1−メチルエチレン、2−メチルエチレン基等が挙げられ、中でも1−メチルエチレン、2−メチルエチレン基が更に好ましい。 The divalent hydrocarbon group having 1 to 6 carbon atoms represented by R 2a and R 2b is preferably a linear or branched alkylene group having 2 to 6 carbon atoms, and R 2a and R 2b are the same. The case is preferred. Particularly preferred divalent hydrocarbon groups include ethylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, 1-methylethylene, 2-methylethylene groups, etc. Among them, 1-methylethylene and 2-methylethylene groups are preferred. Further preferred.

3で示される炭素数2〜6の二価の炭化水素基としては、炭素数2〜6の直鎖又は分岐鎖のアルキレン基が好ましく、中でもエチレン、トリメチレン、テトラメチレン、ペンタメチレン、ヘキサメチレン、1−メチルエチレン、2−メチルエチレン基、2,2−ジメチルトリメチレン等が好ましく、特にエチレン、1−メチルエチレン、2−メチルエチレン基が好ましい。 The divalent hydrocarbon group having 2 to 6 carbon atoms represented by R 3 is preferably a linear or branched alkylene group having 2 to 6 carbon atoms, among which ethylene, trimethylene, tetramethylene, pentamethylene, hexamethylene 1-methylethylene, 2-methylethylene group, 2,2-dimethyltrimethylene and the like are preferable, and ethylene, 1-methylethylene and 2-methylethylene group are particularly preferable.

また、nとしては1〜50の数が好ましく、1〜10の数がより好ましく、4未満の数が特に好ましい。   Moreover, as n, the number of 1-50 is preferable, the number of 1-10 is more preferable, and the number of less than 4 is especially preferable.

好ましいジアミド誘導体(1)としては、一般式(1)中のR1a、R1b、R2a、R2b、R3及びnが好ましいものとして上記で示した基を組合わせた化合物が挙げられるが、中でもR1a、R1b、R2a、R2b及びR3の炭化水素基の一部又は全部が分岐鎖を有する化合物は低融点で配合性に優れることから、全てが直鎖状炭化水素より構成される化合物に比べて好ましい。
本発明の外用剤組成物に用いるジアミド誘導体(1)は、公知のアミド合成法によって製造することができ、例えば次の製造法によれば効率的かつ安価に製造できる。
Preferred examples of the diamide derivative (1) include compounds in which R 1a , R 1b , R 2a , R 2b , R 3 and n in the general formula (1) are preferably combined with the groups shown above. Of these, compounds in which some or all of the hydrocarbon groups of R 1a , R 1b , R 2a , R 2b, and R 3 have a branched chain have a low melting point and are excellent in compounding properties. It is preferable compared with the compound comprised.
The diamide derivative (1) used in the external preparation composition of the present invention can be produced by a known amide synthesis method. For example, it can be produced efficiently and inexpensively by the following production method.

(式中、R1a、R1b、R2a、R2b、R3及びnは前記と同様の意味を示す。) (In the formula, R 1a , R 1b , R 2a , R 2b , R 3 and n have the same meaning as described above.)

すなわち、対応するジアミン(3)とカルボン酸(4a)及び/又は(4b)又はその反応性誘導体(エステル、酸ハライド、酸無水物等)を反応させることにより、目的のジアミド誘導体(1)を効率的に得ることができる。   That is, the target diamide derivative (1) is obtained by reacting the corresponding diamine (3) with the carboxylic acid (4a) and / or (4b) or a reactive derivative thereof (ester, acid halide, acid anhydride, etc.). Can be obtained efficiently.

この反応の条件としては、ジシクロヘキシルカルボジイミド等の脱水剤又は水酸化カリウム、水酸化ナトリウム等のアルカリ金属水酸化物、水酸化カルシウム等のアルカリ土類金属水酸化物、炭酸カリウム等のアルカリ金属炭酸塩、炭酸カルシウム等のアルカリ土類金属炭酸塩、ナトリウムメトキシド、ナトリウムエトキシド、カリウム−tert−ブトキシド等のアルカリ金属アルコラート、トリエチルアミン、ピリジン等の3級アミン等の塩基の存在下或いは非存在下、常圧〜1.3Paの減圧下に室温〜300℃で反応させることが好ましい。この際、カルボン酸(4a)及び/又は(4b)又はその反応性誘導体をジアミン(3)に対して過剰、すなわち2当量以上用いるのが好ましく、また反応により生じる水又はアルコールを系外に除去しながら行なうと、反応が速く進行するので好ましい。このようにして得られるジアミド誘導体(1)は、水洗、液−液分配、カラムクロマトグラフィー、蒸留、結晶化、再結晶化や粉体処理等の公知の方法により精製することもできる。   The conditions for this reaction include a dehydrating agent such as dicyclohexylcarbodiimide, an alkali metal hydroxide such as potassium hydroxide and sodium hydroxide, an alkaline earth metal hydroxide such as calcium hydroxide, and an alkali metal carbonate such as potassium carbonate. In the presence or absence of bases such as alkaline earth metal carbonates such as calcium carbonate, alkali metal alcoholates such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, tertiary amines such as triethylamine, pyridine, The reaction is preferably performed at room temperature to 300 ° C. under a reduced pressure of normal pressure to 1.3 Pa. At this time, it is preferable to use the carboxylic acid (4a) and / or (4b) or a reactive derivative thereof in excess, that is, 2 equivalents or more with respect to the diamine (3). However, it is preferable because the reaction proceeds quickly. The diamide derivative (1) thus obtained can also be purified by known methods such as washing with water, liquid-liquid distribution, column chromatography, distillation, crystallization, recrystallization and powder treatment.

尚、ジアミン(3)としては、ポリオキシエチレンジアミン、ポリオキシプロピレンジアミン、ポリオキシエチレン−オキシプロピレンジアミンが挙げられ、これらの具体例としては、ジェファーミン(「JEFFAMINE」(登録商標)、ハンツマン社(HUNTSMAN CORPORATION))ポリオキシアルキレンジアミン類を挙げることができる。   Examples of the diamine (3) include polyoxyethylene diamine, polyoxypropylene diamine, and polyoxyethylene-oxypropylene diamine. Specific examples thereof include Jeffamine (“JEFFAMINE” (registered trademark), Huntsman ( HUNTSMAN CORPORATION)) polyoxyalkylene diamines.

かくして得られる本発明のジアミド誘導体(1)は、後記実施例に示すように、皮膚角質層のバリアー機能を維持改善し、角質層の水分保持能力を向上する効果を有するため、保湿剤及び皮膚バリアー機能補強剤として有用であり、これを含有する外用剤組成物は荒れ肌の改善等に有効である。   The diamide derivative (1) of the present invention thus obtained has an effect of maintaining and improving the barrier function of the skin stratum corneum and improving the moisture retention ability of the stratum corneum, as shown in the examples below. It is useful as a barrier function reinforcing agent, and an external preparation composition containing the same is effective for improving rough skin.

本発明では、多価アルコール、有機酸若しくはその塩又はその誘導体及び植物エキスから選ばれる水溶性保湿剤を組み合わせると、角質層の水分保持能力を相乗的に増加することが可能である。   In the present invention, when a water-soluble humectant selected from a polyhydric alcohol, an organic acid or a salt or derivative thereof and a plant extract is combined, it is possible to synergistically increase the water retention capacity of the stratum corneum.

多価アルコールとしては、例えばグリセリン、ジグリセリン、トリグリセリン、テトラグリセリン等のポリグリセリン、エチレングリコール、1,3−ブチレングリコール、1,4−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、ポリエチレングリコール、1,3−プロパンジオール、グルコース、マルトース、マルチトール、ショ糖、フラクトース、キシリトール、ソルビトール、マルトトリオース、スレイトール、エリスルトール、デンプン分解還元アルコール、ソルビット、ポリオキシアルキレンアルキルグルコシド等が挙げられる。これらのうち、特にグリセリン、1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコールが好ましい。   Examples of the polyhydric alcohol include polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene glycol, 1 , 3-propanediol, glucose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriose, threitol, erythritol, amylolytic reducing alcohol, sorbit, polyoxyalkylene alkyl glucoside and the like. Of these, glycerin, 1,3-butylene glycol, propylene glycol, and dipropylene glycol are particularly preferable.

多価アルコールは、2種以上を併用しても良い。本発明の外用剤組成物中における含有量は、0.001〜50重量%(以下、単に%で示す)、好ましくは0.01〜40%、特に好ましくは0.1〜30%とすると、角質層の水分保持能力を相乗的に高めることが可能である。   Two or more polyhydric alcohols may be used in combination. The content in the external preparation composition of the present invention is 0.001 to 50% by weight (hereinafter, simply expressed as%), preferably 0.01 to 40%, particularly preferably 0.1 to 30%. It is possible to synergistically increase the water retention capacity of the stratum corneum.

有機酸及び有機酸誘導体としては、グリコール酸、乳酸、クエン酸、2−ヒドロキシオクタン酸等の炭素数2〜28のオキシカルボン酸;コハク酸、フマル酸、マレイン酸、マロン酸、1,3−プロパンジカルボン酸等の炭素数2〜12のジカルボン酸;アスパラギン酸、アスパラギン、グリシン、グルタミン酸、グルタミン、γ−アミノ酪酸、アルギニン、システイン、アラニン等のアミノ酸及びその誘導体;コハク酸オクチル、マレイン酸メチル等のジカルボン酸モノエステル;ニコチン酸、ニコチン酸メチル、ニコチン酸エチル、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸トコフェロール、キノリン酸、ピリジン−3,5−ジカルボン酸、ニコチン酸アミドアデニンジヌクレオチドリン酸(NADP)、ニコチン酸モノヌクレオチド、ニコチニルアルコール、酒石酸ニコチニルアルコール等のニコチン酸若しくはその塩又はその誘導体及び一般式(5)   Examples of organic acids and organic acid derivatives include glycolic acid, lactic acid, citric acid, 2-hydroxyoctanoic acid and other oxycarboxylic acids having 2 to 28 carbon atoms; succinic acid, fumaric acid, maleic acid, malonic acid, 1,3- C2-C12 dicarboxylic acids such as propanedicarboxylic acid; amino acids such as aspartic acid, asparagine, glycine, glutamic acid, glutamine, γ-aminobutyric acid, arginine, cysteine, alanine and the like; octyl succinate, methyl maleate, etc. Dicarboxylic acid monoesters of: nicotinic acid, methyl nicotinate, ethyl nicotinate, benzyl nicotinate, nicotinamide, tocopherol nicotinate, quinolinic acid, pyridine-3,5-dicarboxylic acid, nicotinamide adenine dinucleotide phosphate ( NADP), mononuclear nicotinate Fault, nicotinyl alcohol, nicotinic acid or a salt thereof, such as tartaric nicotinyl alcohol or its derivatives and the formula (5)

で表されるステリン誘導体が挙げられる。 The sterin derivative represented by these is mentioned.

上記ステリン誘導体としては、一般式(5)中に、lが2〜5のものが、R6はヘキサデセニル、オクタデセニルが、R5はコレステリル、シトステリルが好ましい。 As the above-mentioned sterine derivative, those having 1 to 5 in general formula (5), R 6 is preferably hexadecenyl and octadecenyl, and R 5 is preferably cholesteryl or cytosteryl.

斯かる有機酸、有機酸誘導体としては、α−ヒドロキシカルボン酸、アミノ酸、ニコチン酸及びそれらの誘導体等が好ましく、グリコール酸、乳酸、クエン酸、コハク酸、アスパラギン酸、グリシン、アルギニン、ニコチン酸アミド、ニコチン酸トコフェロール、グリシンベタインが特に好ましい。   As such organic acid and organic acid derivative, α-hydroxycarboxylic acid, amino acid, nicotinic acid and derivatives thereof are preferable, and glycolic acid, lactic acid, citric acid, succinic acid, aspartic acid, glycine, arginine, nicotinic acid amide Particularly preferred are tocopherol nicotinate and glycine betaine.

また、有機酸の塩としては、例えば乳酸、クエン酸、コハク酸等のカリウム、ナトリウム、マグネシウム、カルシウム、アルミニウム、塩基性アミノ酸塩が挙げられ、有機酸が塩基性基を有する場合は、例えば、塩酸、硫酸、硝酸、リン酸等の酸付加塩が挙げられる。   Examples of the organic acid salt include potassium, sodium, magnesium, calcium, aluminum, basic amino acid salts such as lactic acid, citric acid, and succinic acid. When the organic acid has a basic group, for example, Acid addition salts such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like can be mentioned.

有機酸若しくはその塩又はその誘導体は2種以上を併用しても良い。本発明の外用剤組成物中における含有量は、0.0001〜10%、特に0.001〜5%含有するのが好ましい。   Two or more organic acids or salts or derivatives thereof may be used in combination. The content in the external preparation composition of the present invention is preferably 0.0001 to 10%, particularly preferably 0.001 to 5%.

植物エキスとしては、例えば特開平9−165313号公報に記載されるものが挙げられる。これらのうち、特に、ユーカリ、ホップ、ショウガ、キキョウ、ガンピールノキ、ノイバラ、セイヨウトウキ、ユリ、ハトムギ、ガマ、ビワ、クチナシ、オタネニンジン、サボンソウ、シラカバ、アマチャ、チョウジ、ベニバナ、ワレモコウ、イリス、クララに由来する抽出物、水蒸気蒸留物若しくは圧搾物が好ましい。抽出溶剤としては、水、エタノール、1,3−ブチレングリコール等が挙げられる。
植物エキスは2種以上を併用しても良い。本発明の外用剤組成物中における含有量は、乾燥固型分に換算して、0.0001〜10%、特に0.0001〜5%含有するのが好ましい。
Examples of the plant extract include those described in JP-A-9-165313. Of these, eucalyptus, hops, ginger, kyoto, gumpiroki, wild rose, pearl oysters, lilies, pearl barley, cattails, loquat, gardenia, ginseng, bonnet, birch, amacha, clove, safflower, burdock, iris, and clara Extracts, steam distillates or pressed products are preferred. Examples of the extraction solvent include water, ethanol, 1,3-butylene glycol and the like.
Two or more kinds of plant extracts may be used in combination. The content in the external preparation composition of the present invention is preferably 0.0001 to 10%, particularly preferably 0.0001 to 5% in terms of dry solid content.

また、本発明では、セラミド類、プソイドセラミド、スフィンゴ糖脂質、スフィンゴリン脂質、スフィンゴシン及びその誘導体、スフィンガニン及び誘導体、高級脂肪酸、コレステロール及びその誘導体等から選ばれる角質細胞間脂質成分を組み合わせることにより、角質層のバリアー機能を相乗的に増加することが可能である。   In the present invention, by combining keramide intercellular lipid components selected from ceramides, pseudoceramides, glycosphingolipids, sphingophospholipids, sphingosine and derivatives thereof, sphinganine and derivatives, higher fatty acids, cholesterol and derivatives thereof, and the like. It is possible to synergistically increase the barrier function of the stratum corneum.

セラミド類には、脳や皮膚から抽出、精製された天然セラミドと微生物学的方法又は化学的方法によって合成された合成セラミドが含まれる。
天然セラミドとしては、タイプI〜タイプVIIのセラミド、N−オレオイルスフィンゴシン、N−(12−ヒドロキシオクタデカノイル)スフィンゴシン、N−(16−ヒドロキシヘキサデカノイル)スフィンゴシン、牛脳セラミド等が挙げられる。
合成セラミドの合成法としては、例えば特開昭59−7118号公報、特開平4−342553号公報、WO93/22281号公報等に記載された方法を用いることができる。
一方、プソイドセラミドは、例えば特開昭62−228048号公報、特開昭63−216852号公報等に記載された方法に従って製造することができる。プソイドセラミドとして特に好ましいものとしては、次式(6)で表される化合物が挙げられる。
Ceramides include natural ceramides extracted and purified from the brain and skin and synthetic ceramides synthesized by microbiological or chemical methods.
Examples of natural ceramides include ceramides of type I to type VII, N-oleoyl sphingosine, N- (12-hydroxyoctadecanoyl) sphingosine, N- (16-hydroxyhexadecanoyl) sphingosine, bovine brain ceramide and the like. .
As a method for synthesizing the synthetic ceramide, for example, methods described in JP-A-59-7118, JP-A-4-342553, WO93 / 22281 and the like can be used.
On the other hand, pseudoceramide can be produced according to the methods described in, for example, JP-A-62-228048 and JP-A-63-216852. Particularly preferred as pseudoceramide is a compound represented by the following formula (6).

(式中、R7は炭素数9〜17のアルキル基を示し、R8は炭素数10〜18のアルキル基を示す) (Wherein R 7 represents an alkyl group having 9 to 17 carbon atoms, and R 8 represents an alkyl group having 10 to 18 carbon atoms)

スフィンゴ糖脂質及びスフィンゴリン脂質としては、前述のセラミド類と同様に天然由来のものと合成物とがある。スフィンゴ糖脂質は、例えば、構成糖がグルコース、マンノース、ガラクトース、グルクロン酸、グルコサミン等からなるものが挙げられ、セレブロシド及びその硫酸エステルも含まれる。スフィンゴリン脂質としては、スフィンゴミエリンが例示される。   As the sphingoglycolipid and sphingophospholipid, there are naturally derived ones and synthetic ones as well as the ceramides described above. Examples of the sphingoglycolipid include those in which the constituent sugar is composed of glucose, mannose, galactose, glucuronic acid, glucosamine, and the like, and also include cerebroside and sulfate thereof. Examples of sphingophospholipids include sphingomyelin.

セラミド類、プソイドセラミド、スフィンゴ糖脂質、スフィンゴリン脂質と併用するのが好ましいスフィンゴシン類としては、特開平5−85924号公報に開示されているスフィンゴシン類、特開平6−271446号公報で開示される一般式(7)で表される化合物、特開平5−194185号公報に開示される一般式(8)で表される化合物が好ましい。   Sphingosines preferably used in combination with ceramides, pseudoceramides, glycosphingolipids, and sphingophospholipids are disclosed in JP-A-5-85924 and in JP-A-6-271446. The compound represented by the general formula (7) and the compound represented by the general formula (8) disclosed in JP-A-5-194185 are preferred.

特開平5−85924号公報に開示されているスフィンゴシン類は、スフィンゴシン(スフィンゲニン)、ジヒドロスフィンゴシン(スフィンガニン)、フィトスフィンゴシン、デヒドロスフィンゴシン、デヒドロフィトスフィンゴシン、スフィンガジエニン及びこれらのN−メチル体又はN,N−ジメチル体等が挙げられる。これらの化合物の炭化水素基の炭素数は12〜24が好ましく、直鎖又は分岐鎖の飽和又は不飽和のいずれでも良い。   The sphingosines disclosed in JP-A-5-85924 are sphingosine (sphingenin), dihydrosphingosine (sphinganine), phytosphingosine, dehydrosphingosine, dehydrophytosphingosine, sphingadienin and their N-methyl or N , N-dimethyl form and the like. The carbon number of the hydrocarbon group of these compounds is preferably 12 to 24, and may be either linear or branched saturated or unsaturated.

また特開平6−271446号公報開示の化合物(7)は、   Further, the compound (7) disclosed in JP-A-6-271446 is

また特開平5−194185号公報開示の化合物(8)は、   Further, the compound (8) disclosed in JP-A-5-194185 is

(式中、R10は炭素数4〜40の直鎖、分岐鎖、又は環状の飽和若しくは不飽和の炭化水素基を示し、R11、R12、R13、R14及びR15はそれぞれ水素原子、又は1個以上の水酸基が置換していてもよい炭素数1〜10の炭化水素基を示す)
で表されるものである。
(In the formula, R 10 represents a linear, branched, or cyclic saturated or unsaturated hydrocarbon group having 4 to 40 carbon atoms, and R 11 , R 12 , R 13 , R 14, and R 15 are each hydrogen. An atom or a hydrocarbon group having 1 to 10 carbon atoms which may be substituted by one or more hydroxyl groups)
It is represented by

高級脂肪酸としては、炭素数12以上のもの、特に12〜24のものが好ましく、ミリスチン酸、パルミチン酸、パルミトオレイン酸、ステアリン酸、オレイン酸、リノール酸、ベヘン酸等が挙げられる。また、それらの高級脂肪酸を豊富に含むモノグリセライド、ジグリセライド、トリグリセライドを配合しても良い。   As the higher fatty acid, those having 12 or more carbon atoms, particularly those having 12 to 24 carbon atoms are preferable, and examples include myristic acid, palmitic acid, palmitooleic acid, stearic acid, oleic acid, linoleic acid, and behenic acid. Moreover, you may mix | blend the monoglyceride, diglyceride, and triglyceride which are rich in those higher fatty acids.

コレステロールエステルとしては、炭素数12以上の、特に12〜24の高級脂肪酸から成るものが好ましく、パルミチン酸コレステロール、イソステアリン酸コレステロール、N−ラウロイル−L−グルタミン酸ジ(コレステロール、2−オクチルドデシル)、ラノリン脂肪酸コレステロール、マカデミアンナッツ油脂肪酸コレステロール等が挙げられる。   As the cholesterol ester, those consisting of higher fatty acids having 12 or more carbon atoms, particularly 12 to 24 carbon atoms, are preferred, such as cholesterol palmitate, cholesterol isostearate, N-lauroyl-L-glutamate (cholesterol, 2-octyldodecyl), lanolin. Examples include fatty acid cholesterol and macadamian nut oil fatty acid cholesterol.

角質細胞間脂質成分は2種以上を併用しても良い。本発明の外用剤組成物中における含有量は、0.001〜20%、特に0.005〜10%が好ましい。
本発明の外用剤組成物におけるジアミド誘導体(1)の含有量は、通常、乳化型の皮膚外用剤の場合には全組成の0.001〜50%が好ましく、スクワラン等の液状炭化水素を基剤とする油性の皮膚外用剤の場合には全組成の0.01〜50%が好ましく、いずれの場合も特に好ましくは0.01〜20%である。特に肌荒れの予防・改善には0.1〜20%含有することが好ましい。
Two or more keratinocyte lipid components may be used in combination. The content in the external preparation composition of the present invention is preferably 0.001 to 20%, particularly preferably 0.005 to 10%.
The content of the diamide derivative (1) in the external preparation composition of the present invention is usually preferably 0.001 to 50% of the total composition in the case of an emulsified skin external preparation, and is based on a liquid hydrocarbon such as squalane. In the case of an oily external preparation for skin, 0.01 to 50% of the total composition is preferable, and in any case, 0.01 to 20% is particularly preferable. It is preferable to contain 0.1 to 20% especially for prevention and improvement of rough skin.

本発明の外用剤組成物は、その使用形態において薬用皮膚外用剤と化粧料に大別されるが、化粧料、特に皮膚化粧料として用いるのが好ましい。
薬用皮膚外用剤としては、例えば薬効成分を含有する各種軟膏剤を挙げることができる。軟膏剤としては、油性基剤をベースとするもの、水中油型又は油中水型の乳化系基剤をベースとするもののいずれであってもよい。油性基剤としては、例えば植物油、動物油、合成油、脂肪酸及び天然又は合成のグリセライド等が挙げられる。薬効成分としては、例えば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収斂剤、皮膚軟化剤、ホルモン剤等を必要に応じて使用することができる。
The external preparation composition of the present invention is broadly classified into medicinal skin external preparations and cosmetics in its usage form, but is preferably used as cosmetics, particularly skin cosmetics.
Examples of the medicinal skin external preparation include various ointments containing medicinal ingredients. The ointment may be either an oil-based base or an oil-in-water or water-in-oil emulsion base. Examples of the oily base include vegetable oils, animal oils, synthetic oils, fatty acids, and natural or synthetic glycerides. As the medicinal component, for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, an astringent agent, an emollient, a hormone agent and the like can be used as necessary.

化粧料(皮膚化粧料及び毛髪化粧料を含む)として使用する場合は、必須成分であるジアミド誘導体(1)の他に、化粧料成分として一般に使用されている油分、界面活性剤、保湿剤、紫外線吸収剤、美白剤、しわ改善剤、アルコール類、キレート剤、pH調整剤、防腐剤、増粘剤、色素、香料等を任意に組合せて含有させることができる。   When used as cosmetics (including skin cosmetics and hair cosmetics), in addition to the diamide derivative (1) which is an essential component, oils, surfactants, moisturizers generally used as cosmetic components, Ultraviolet absorbers, whitening agents, wrinkle improving agents, alcohols, chelating agents, pH adjusting agents, preservatives, thickeners, pigments, fragrances and the like can be contained in any combination.

化粧料としては、種々の形態、例えば油中水型又は水中油型の乳化化粧料、クリーム、化粧乳液、化粧水、油性化粧料、口紅、ファンデーション、入浴剤、皮膚洗浄剤、爪手入れ剤、毛髪化粧料等が挙げられる。毛髪化粧料としては、例えばヘアトニック、整髪料、ヘアリンス、ヘアトリートメント、ヘアコンディショナー、ヘアスタイリング剤、シャンプー、養毛剤、育毛剤等が挙げられる。   As cosmetics, various forms such as water-in-oil or oil-in-water emulsified cosmetics, creams, cosmetic emulsions, lotions, oily cosmetics, lipsticks, foundations, bathing agents, skin cleansing agents, nail care agents, Examples include hair cosmetics. Examples of hair cosmetics include hair tonics, hair styling agents, hair rinses, hair treatments, hair conditioners, hair styling agents, shampoos, hair nourishing agents, hair restorers and the like.

本発明の外用剤組成物中、薬用皮膚外用剤、皮膚化粧料には、非イオン界面活性剤、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤等の界面活性剤等を含有させることができる。このうち、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、脂肪酸モノグリセライド、グリセリルエーテル等の非イオン界面活性剤が好ましい。その含有量は、組成物中0.01〜20%、特に0.1〜10%が好ましい。   In the external preparation composition of the present invention, a medicinal skin external preparation or skin cosmetic contains a surfactant such as a nonionic surfactant, an anionic surfactant, a cationic surfactant, or an amphoteric surfactant. Can do. Among these, nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, fatty acid monoglyceride, and glyceryl ether are preferable. The content is preferably 0.01 to 20%, particularly preferably 0.1 to 10% in the composition.

また、毛髪化粧料として使用する場合、ジアミド誘導体(1)の含有量は、例えばシャンプー等にあっては0.001〜5%、リンス、トリートメント、コンディショナー、スタイリング剤等にあっては0.1〜20%、ヘアリキッド、ヘアトニック等にあっては0.01〜5%程度が好ましい。   When used as a hair cosmetic, the content of the diamide derivative (1) is, for example, 0.001 to 5% for shampoos and the like, and 0.1 for rinses, treatments, conditioners, styling agents and the like. About 0.01 to 5% is preferable for ˜20%, hair liquid, hair tonic and the like.

当該毛髪化粧料には、アニオン界面活性剤、カチオン界面活性剤、非イオン界面活性剤、両性界面活性剤等の界面活性剤、その他毛髪化粧料に一般に用いられる成分を含有させることができる。毛髪化粧料がシャンプーである場合、アルキルエーテル硫酸塩、アルキル硫酸塩、オレフィンスルホン酸塩等のアニオン界面活性剤を主活性剤として含有させることができる。その含有量は、組成物中5〜30%、特に10〜20%が好ましい。   The hair cosmetic may contain an anionic surfactant, a cationic surfactant, a nonionic surfactant, a surfactant such as an amphoteric surfactant, and other components generally used in hair cosmetics. When the hair cosmetic is a shampoo, an anionic surfactant such as an alkyl ether sulfate, an alkyl sulfate, or an olefin sulfonate can be contained as a main active agent. The content thereof is preferably 5 to 30%, particularly 10 to 20% in the composition.

本発明化粧料がヘアリンス、コンディショナー、ヘアトリートメント、ヘアスタイリング剤である場合、毛髪に良好な感触を付与するため、モノ−又はジ−長鎖アルキル四級アンモニウム塩等のカチオン界面活性剤、ポリオキシエチレンアルキル又はアルケニルエーテル等の非イオン界面活性剤、及び流動パラフィン等の油脂類を含有させることができる。カチオン及びノニオン界面活性剤の含有量は、組成物中0.1〜50%、特に0.5〜20%が好ましい。   When the cosmetic composition of the present invention is a hair rinse, a conditioner, a hair treatment, or a hair styling agent, a cationic surfactant such as mono- or di-long chain alkyl quaternary ammonium salt, polyoxy Nonionic surfactants such as ethylene alkyl or alkenyl ether, and fats and oils such as liquid paraffin can be contained. The content of the cationic and nonionic surfactant is preferably 0.1 to 50%, particularly preferably 0.5 to 20% in the composition.

さらに、毛髪化粧料がヘアリキッド、ヘアトニック等である場合は、ポリオキシエチレン等の非イオン界面活性剤を含有させることができる。非イオン界面活性剤は、全組成中、0.01〜20%、特に0.1〜5%含有させることが好ましい。   Furthermore, when hair cosmetics are hair liquid, hair tonic, etc., nonionic surfactants, such as polyoxyethylene, can be contained. The nonionic surfactant is preferably contained in the total composition in an amount of 0.01 to 20%, particularly 0.1 to 5%.

製造例1
化合物(A)の製造
Production Example 1
Production of compound (A)

攪拌装置、窒素導入管及び蒸留装置を備えたフラスコに、カプリル酸(花王製ルナック8−98(E))317gを仕込み、窒素気流下、攪拌下220℃でジェファーミンD−230(ハンツマン社製)228gを2.5時間かけて滴下した。同条件下で5時間熟成した。以上の滴下と熟成は、窒素気流下で行なうことにより、副生してくる水を留去しながら行なった。反応終了後、分子蒸留(160〜210℃、0.5Pa)を行ない、標記化合物(A)262gを得た。得られた化合物(A)の物性は以下の通りである。   A flask equipped with a stirrer, a nitrogen inlet tube and a distillation apparatus was charged with 317 g of caprylic acid (Lunac 8-98 (E) manufactured by Kao), and Jeffamine D-230 (manufactured by Huntsman) at 220 ° C. under nitrogen flow with stirring. ) 228 g was added dropwise over 2.5 hours. The mixture was aged for 5 hours under the same conditions. The above dripping and ripening were carried out while distilling off by-produced water by carrying out under a nitrogen stream. After completion of the reaction, molecular distillation (160-210 ° C., 0.5 Pa) was performed to obtain 262 g of the title compound (A). The physical properties of the obtained compound (A) are as follows.

無色油状物
1H-NMR(CDCl3,δ);0.80-1.00(m), 1.00-1.50(m), 1.50-1.80(m), 2.13(t,J=7.5Hz), 3.00-3.75(m), 4.00-4.30(m), 5.60-6.10(m).
Colorless oil
1 H-NMR (CDCl 3 , δ); 0.80-1.00 (m), 1.00-1.50 (m), 1.50-1.80 (m), 2.13 (t, J = 7.5 Hz), 3.00-3.75 (m), 4.00 -4.30 (m), 5.60-6.10 (m).

製造例2〜11
ジアミン(3)とカルボン酸(4a)又は(4b)として表1に示す化合物を用いた以外は製造例1と同様にして下記の化合物(B)〜(k)を製造した。各ジアミド誘導体の物性を併せて表1及び表2に示す。
Production Examples 2-11
The following compounds (B) to (k) were produced in the same manner as in Production Example 1 except that the compounds shown in Table 1 were used as the diamine (3) and the carboxylic acid (4a) or (4b). The physical properties of each diamide derivative are shown together in Table 1 and Table 2.

試験例1
製造例1〜11で製造した各ジアミド誘導体を含有する表3〜表5に示す組成の本発明の外用剤組成物(本発明品)をそれぞれ調製し、これらの外用剤について下記の方法により経皮水分蒸散及び経皮吸収を測定評価した。その結果を下記表6に示す。
(試験方法)
Test example 1
The preparations for external use of the present invention (products of the present invention) having the compositions shown in Tables 3 to 5 containing the diamide derivatives produced in Production Examples 1 to 11 were prepared, respectively, and these external preparations were subjected to the following method. Skin moisture transpiration and transdermal absorption were measured and evaluated. The results are shown in Table 6 below.
(Test method)

必須脂肪酸を含まない飼料のみでウィスター(Wister)系雄性ラットを飼育し、必須脂肪酸欠乏症の症状を有するラットを本試験に用いた。これら必須脂肪酸欠乏症ラットの背部を丁寧に剃毛した後、外用剤組成物を1日1回12日間塗布した。なお、それぞれの評価外用剤に対して1群5匹ずつを本試験に供した。塗布を終了してから3日後、下記の項目について測定評価を行なった。   Wister male rats were bred only on diets that did not contain essential fatty acids, and rats with symptoms of essential fatty acid deficiency were used in this study. After carefully shaving the back of these essential fatty acid deficient rats, the external preparation composition was applied once a day for 12 days. In addition, 5 animals per group were used for this test for each external preparation for evaluation. Three days after the application was completed, the following items were measured and evaluated.

(1)経皮水分蒸散
試験ラットの背部の経皮水分蒸散量をテバメーターにて測定した。下記式に従い、経皮水分蒸散抑制効果を求めた。
本発明品の経皮水分蒸散抑制度=
比較品1塗布ラットの経皮水分蒸散量−本発明品塗布ラットの経皮水分蒸散量(g/m2/hr)
(1) Transcutaneous moisture transpiration The transdermal moisture transpiration of the back of the test rat was measured with a tevameter. The transdermal moisture transpiration inhibitory effect was determined according to the following formula.
Inhibition degree of transdermal moisture transpiration of the product of the present invention =
Percutaneous moisture transpiration of the comparison product 1 applied rat-Transdermal water transpiration of the rat applied with the present invention (g / m 2 / hr)

(2)経皮吸収
試験ラットの背部皮膚を切取り、経皮吸収用チャンバーに表皮側を上にして固定した。下部受器にはリン酸緩衝塩類溶液を満たし、表皮上部には37KBqの14C−サリチル酸を含むリン酸緩衝塩類溶液を加え静置した。19時間後、下部受器から一定量のリン酸緩衝塩類溶液を抜取り、浸透してきた14C−サリチル酸
の放射活性を測定した。下記式に従い、経皮吸収抑制効果を求めた。
本発明品の経皮吸収抑制度=
比較品1塗布ラットの経皮吸収量−本発明塗布ラットの経皮吸収量(dpm)
(2) Percutaneous absorption The back skin of the test rat was cut out and fixed to the percutaneous absorption chamber with the epidermis side up. The lower receiver was filled with a phosphate buffered saline solution, and a phosphate buffered saline solution containing 37 KBq of 14 C-salicylic acid was added to the upper part of the epidermis and allowed to stand. After 19 hours, a certain amount of phosphate buffered saline was withdrawn from the lower receiver, and the radioactivity of 14 C-salicylic acid that had permeated was measured. The percutaneous absorption inhibitory effect was determined according to the following formula.
Degree of percutaneous absorption suppression of the product of the present invention =
Comparative product 1 percutaneous absorption of rats coated with this product-percutaneous absorption of rats coated with the present invention (dpm)

本発明品1〜11は、比較品1に比べて優れた経皮水分蒸散及び経皮吸収の抑制効果を有し、肌荒れ改善効果に優れていた。   The inventive products 1 to 11 had an excellent effect of suppressing transdermal moisture transpiration and transdermal absorption compared with the comparative product 1, and were excellent in the rough skin improvement effect.

試験例2
ジアミド誘導体を含有する表7及び表8に示す組成の本発明の外用剤組成物(本発明品)をそれぞれ調製し、これらの外用剤について下記の方法により経皮水分蒸散及び皮膚コンダクタンスについて測定評価した。また、比較として、皮膚閉塞性が高いことが知られ、薬用皮膚外用剤や皮膚化粧料に用いられているワセリンを含有する外用剤組成物(比較品2)についても同様の測定評価を行なった。結果を表9に示す。
Test example 2
The preparations for external use of the present invention (products of the present invention) of the present invention having the compositions shown in Table 7 and Table 8 containing diamide derivatives were prepared, respectively, and percutaneous moisture transpiration and skin conductance were measured and evaluated for these external preparations by the following methods. did. Further, as a comparison, the same measurement and evaluation was performed for an external preparation composition (comparative product 2) containing petrolatum, which is known to have high skin occlusive properties and is used in medicinal skin external preparations and skin cosmetics. . The results are shown in Table 9.

(試験方法)
健常人10人の前腕内側部(両腕)を洗浄後、アセトン/エーテル(1/1)処理により角質層細胞間脂質を取り除き、荒れ肌にした。被験部位に外用剤組成物を1日2回3日間塗布し、翌日同部位を洗浄し、室温20℃、湿度30%で20分安静にした後、下記の項目について測定評価を行なった。
(1)経皮水分蒸散
(Test method)
After washing the inner forearm (both arms) of 10 healthy people, the stratum corneum intercellular lipid was removed by acetone / ether (1/1) treatment to make rough skin. The external preparation composition was applied to the test site twice a day for 3 days, the same site was washed the next day and allowed to rest at room temperature of 20 ° C. and a humidity of 30% for 20 minutes, and then the following items were measured and evaluated.
(1) Transdermal moisture transpiration

経皮水分蒸散量をテバメーターにて測定した。下記式に従い、経皮水分蒸散抑制効果を求めた。
本発明品の経皮水分蒸散抑制度=
基剤塗布部の経皮水分蒸散量−本発明品塗布部の経皮水分蒸散量(g/m2/hr)
The transdermal moisture transpiration was measured with a tevameter. The transdermal moisture transpiration inhibitory effect was determined according to the following formula.
Inhibition degree of transdermal moisture transpiration of the product of the present invention =
Percutaneous moisture transpiration of base application part-Transdermal moisture transpiration of application part of the present invention (g / m 2 / hr)

(2)角質層の水分
角質層の水分含有量を皮膚コンダクタンスメータにて測定した。コンダクタンスが高いほど、角質層の水分含有量が多いことを意味する。下記式に従い、角質層の水分保持能力の改善効果を求めた。
本発明品の水分保持能力改善度=
本発明品塗布部のコンダクタンス−基剤塗布部のコンダクタンス(μS)
(2) Water content of stratum corneum The water content of the stratum corneum was measured with a skin conductance meter. A higher conductance means a higher moisture content in the stratum corneum. According to the following formula, the improvement effect of the water retention ability of the stratum corneum was determined.
Improvement in water retention capacity of the product of the present invention =
Conductance of the application part of the present invention-Conductance of the base application part (μS)

本発明品12〜17は、比較品2に比べて角質層の水分量を増加させる効果、経皮水分蒸散を抑制する効果及び肌荒れを改善する効果に優れていた。   The inventive products 12 to 17 were superior to the comparative product 2 in the effect of increasing the water content of the stratum corneum, the effect of suppressing transdermal moisture transpiration, and the effect of improving rough skin.

試験例3
表10及び表12に示す組成の本発明の外用剤組成物(本発明品)をそれぞれ調製し、これらの外用剤について経皮水分蒸散、皮膚コンダクタンス及び肌あれ状態を評価した。また、比較として、ワセリンを含有する外用剤組成物(比較品2)についても同様の評価を行った。結果を表11及び表13に示す。
(試験方法)
(1)経皮水分蒸散
試験例2と同様に評価した。
(2)角質層の水分
試験例2と同様に評価した。
(3)肌荒れスコア
肌荒れを肉眼で観察し、下記基準により判定した。スコアは平均値で示した。
0:肌荒れを認めない
1:かすかな肌荒れを認める
2:肌荒れを認める
3:ややひどい肌荒れを認める
Test example 3
External preparation compositions of the present invention (products of the present invention) having the compositions shown in Table 10 and Table 12 were prepared, and transdermal moisture transpiration, skin conductance, and rough skin were evaluated for these external preparations. Moreover, the same evaluation was performed also about the external preparation composition (comparative product 2) containing petrolatum for comparison. The results are shown in Table 11 and Table 13.
(Test method)
(1) Transcutaneous moisture transpiration Evaluation was conducted in the same manner as in Test Example 2.
(2) Water content of stratum corneum Evaluation was performed in the same manner as in Test Example 2.
(3) Rough skin score Rough skin was observed with the naked eye and judged according to the following criteria. The score was shown as an average value.
0: Does not recognize rough skin 1: Appears faint rough skin 2: Approves rough skin 3: Appears slightly rough skin

本発明品13及び18〜26は、比較品2に比べて角質層の経皮水分蒸散を抑制する効果及び肌荒れを改善する効果に優れていた。   The inventive products 13 and 18 to 26 were superior to the comparative product 2 in the effect of suppressing transdermal moisture transpiration of the stratum corneum and the effect of improving rough skin.

本発明13及び27〜33は、比較品2に比べて角質層の水分量を増加させる効果及び肌荒れを改善する効果に優れていた。   Inventions 13 and 27 to 33 were excellent in the effect of increasing the amount of water in the stratum corneum and the effect of improving rough skin as compared with Comparative Product 2.

試験例4
ジアミド誘導体を含有する表14及び表15に示す組成の本発明のヘアリンス(本発明品)をそれぞれ調製し、これらのヘアリンスによる処理後の髪のぱさつきと感触を5名のパネラーにより下記基準で評価した。この結果を表16及び表17に示す。
Test example 4
The hair rinses of the present invention having the compositions shown in Table 14 and Table 15 containing the diamide derivatives (Products of the present invention) were prepared, and the hairiness and feel after treatment with these hair rinses were evaluated by the following criteria using five panelists. did. The results are shown in Table 16 and Table 17.

−2:悪い
−1:やや悪い
0:どちらともいえない
+1:やや良い
+2:良い
-2: Bad -1: Slightly bad 0: Cannot say +1: Slightly good +2: Good

本発明品34〜38は、比較品3に比べ毛髪のぱさつきの改善効果と毛髪の感触改善効果に優れていた。   The inventive products 34 to 38 were superior to the comparative product 3 in improving the crispness of the hair and improving the feel of the hair.

実施例1
表18に示す配合でスキンローションを常法に従い製造した。得られたスキンローションは優れた肌荒れ防止・改善効果等を示した。また、化合物(A)、(C)、(D)、(E)、(G)、(K)は、配合性、配合安定性に優れていた。
Example 1
Skin lotions with the formulation shown in Table 18 were produced according to a conventional method. The obtained skin lotion exhibited an excellent effect of preventing and improving rough skin. In addition, the compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

実施例2
表19に示す配合でO/Wクリームを常法に従い製造した。得られたO/Wクリームは優れた肌荒れ防止・改善効果等を示した。化合物(A)、(C)、(D)、(E)、(G)、(K)は配合性、配合安定性に優れていた。
Example 2
O / W creams with the formulation shown in Table 19 were produced according to a conventional method. The obtained O / W cream showed an excellent effect of preventing and improving rough skin. The compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

実施例3
表20に示す配合でシャンプーを常法に従い製造した。このシャンプーは毛髪の感触を向上させ、頭皮の荒れを防止・改善した。化合物(A)、(C)、(D)、(E)、(G)、(K)は配合性、配合安定性に優れていた。
Example 3
A shampoo was produced according to a conventional method with the formulation shown in Table 20. This shampoo improved the feel of the hair and prevented and improved scalp roughness. The compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

実施例4
表21に示す配合でヘアリキッド組成物を常法に従い製造した。得られたヘアリキッド組成物は、毛髪に対して優れたスタイル保持形成性と良好な感触を付与した。化合物(A)、(C)、(D)、(E)、(G)、(K)は配合性、配合安定性に優れていた。
Example 4
A hair liquid composition with the formulation shown in Table 21 was produced according to a conventional method. The obtained hair liquid composition imparted excellent style retention and good feel to the hair. The compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

実施例5
以下に示す組成のナイトクリームを調製した。得られたナイトクリームは皮膚角質層のバリアー機能の低下を回復補強する効果を有し、さらに角質層の水分保持能力を高め、肌荒れ防止・改善効果等を示した。化合物(A)、(C)、(D)、(E)、(G)、(K)は配合性、配合安定性に優れていた。
Example 5
A night cream having the following composition was prepared. The obtained night cream had the effect of recovering and reinforcing the lowering of the barrier function of the skin stratum corneum, further enhancing the water retention ability of the stratum corneum, and exhibiting the effect of preventing and improving rough skin. The compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

実施例6
以下に示す組成のサンスクリーン乳液を調製した。得られたサンスクリーン乳液は皮膚角質層のバリアー機能の低下を回復補強する効果を有し、さらに角質層の水分保持能力を高め、肌荒れ防止・改善効果等を示した。化合物(A)、(C)、(D)、(E)、(G)、(K)は配合性、配合安定性に優れていた。
Example 6
A sunscreen emulsion having the composition shown below was prepared. The obtained sunscreen emulsion has the effect of recovering and reinforcing the decrease in the barrier function of the skin stratum corneum, further enhancing the water retention ability of the stratum corneum, and exhibiting the effect of preventing and improving rough skin. The compounds (A), (C), (D), (E), (G), and (K) were excellent in blendability and blending stability.

Claims (7)

次の一般式(1):
(式中、R1a及びR1bは同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体を含有する外用剤組成物。
The following general formula (1):
Wherein R 1a and R 1b are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent hydrocarbons having 1 to 6 carbon atoms. And R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
The external preparation composition containing the diamide derivative represented by these.
次の一般式(1):
(式中、R1a及びR1bは同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体及び角質細胞間脂質成分を含有する外用剤組成物。
The following general formula (1):
Wherein R 1a and R 1b are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent hydrocarbons having 1 to 6 carbon atoms. And R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
An external preparation composition containing a diamide derivative represented by the formula and a keratinocyte lipid component.
角質細胞間脂質成分がセラミド類、プソイドセラミド、スフィンゴ糖脂質、スフィンゴリン脂質、スフィンゴシン及びその誘導体、スフィンガニン及びその誘導体、高級脂肪酸並びにコレステロール及びその誘導体から選ばれる1種以上である請求項2記載の外用剤組成物。   3. The keratin intercellular lipid component is at least one selected from ceramides, pseudoceramides, glycosphingolipids, sphingophospholipids, sphingosine and derivatives thereof, sphinganine and derivatives thereof, higher fatty acids and cholesterol and derivatives thereof. Topical preparation composition. 化粧料である請求項1〜3のいずれか1項記載の外用剤組成物。   It is a cosmetic, The external preparation composition of any one of Claims 1-3. 次の一般式(1):
(式中、R1a及びR1bは同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体を有効成分とする保湿剤。
The following general formula (1):
Wherein R 1a and R 1b are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent hydrocarbons having 1 to 6 carbon atoms. And R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
A humectant comprising a diamide derivative represented by the formula:
次の一般式(1):
(式中、R1a及びR1bは同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体を有効成分とする皮膚バリアー機能補強剤。
The following general formula (1):
Wherein R 1a and R 1b are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent hydrocarbons having 1 to 6 carbon atoms. And R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
The skin barrier function reinforcing agent which uses the diamide derivative represented by these as an active ingredient.
次の一般式(1'):
(式中、R1a'及びR1b'は同一又は異なって炭素数4〜23の分岐鎖の炭化水素基を示し、R2a及びR2bは同一又は異なって炭素数1〜6の二価の炭化水素基を示し、R3は同一又は異なって炭素数2〜6の二価の炭化水素基を示し、nは1〜100の数を示す。)
で表されるジアミド誘導体。
The following general formula (1 ′):
(Wherein R 1a ′ and R 1b ′ are the same or different and represent a branched hydrocarbon group having 4 to 23 carbon atoms, and R 2a and R 2b are the same or different and are divalent carbon atoms having 1 to 6 carbon atoms. A hydrocarbon group, R 3 is the same or different and represents a divalent hydrocarbon group having 2 to 6 carbon atoms, and n represents a number of 1 to 100.)
The diamide derivative represented by these.
JP2005207051A 2001-03-06 2005-07-15 External preparation composition Expired - Fee Related JP4150738B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005207051A JP4150738B2 (en) 2001-03-06 2005-07-15 External preparation composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001061695 2001-03-06
JP2005207051A JP4150738B2 (en) 2001-03-06 2005-07-15 External preparation composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002020293A Division JP3712676B2 (en) 2001-03-06 2002-01-29 External preparation composition

Publications (2)

Publication Number Publication Date
JP2005306886A true JP2005306886A (en) 2005-11-04
JP4150738B2 JP4150738B2 (en) 2008-09-17

Family

ID=35436032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005207051A Expired - Fee Related JP4150738B2 (en) 2001-03-06 2005-07-15 External preparation composition

Country Status (1)

Country Link
JP (1) JP4150738B2 (en)

Also Published As

Publication number Publication date
JP4150738B2 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
KR100667611B1 (en) Oily material composition
KR100987234B1 (en) Composition for external application
JP4358996B2 (en) External preparation composition
EP2452668B1 (en) Emulsified composition
US9399030B2 (en) Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same
US9616007B2 (en) Composition comprising mixtures of isostearamide, glycerol ester and water
WO2013041388A1 (en) Use of isosorbide derivatives for producing cosmetic preparations
JP4644391B2 (en) Skin preparation
US6531143B1 (en) α-hydroxy fatty acid derivatives and external compositions containing the same
JP3712676B2 (en) External preparation composition
JP4150738B2 (en) External preparation composition
JP4112741B2 (en) Moisturizer
JP3526355B2 (en) Cosmetics
JP4220625B2 (en) External preparation composition
JP2002047261A (en) External preparation composition
JP2001010921A (en) Composition for external use

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080318

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080624

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080630

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110704

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110704

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110704

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120704

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120704

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130704

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees